Rhone Ma Holdings Bhd (5278) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.234x

Based on the latest financial reports, Rhone Ma Holdings Bhd (5278) has a cash flow conversion efficiency ratio of 0.234x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM41.17 Million ≈ $10.34 Million USD) by net assets (RM175.69 Million ≈ $44.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Rhone Ma Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Rhone Ma Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Rhone Ma Holdings Bhd (5278) financial obligations for a breakdown of total debt and financial obligations.

Rhone Ma Holdings Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rhone Ma Holdings Bhd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sangji Caelum Inc
KQ:042940
-0.089x
FNC ADD CULTURE. Co. Ltd
KQ:063440
0.017x
TNR Gold Corp.
V:TNR
-1.253x
Brunswick Exploration Inc
V:BRW
-0.008x
IL&FS Engineering and Construction Company Limited
NSE:IL&FSENGG
0.015x
Orad-M
TA:ORAD
0.098x
TAEYANG Corporation
KQ:053620
0.028x
VirTra Inc
NASDAQ:VTSI
-0.039x

Annual Cash Flow Conversion Efficiency for Rhone Ma Holdings Bhd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Rhone Ma Holdings Bhd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Rhone Ma Holdings Bhd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 RM175.69 Million
≈ $44.11 Million
RM41.17 Million
≈ $10.34 Million
0.234x +128.08%
2024-12-31 RM179.21 Million
≈ $44.99 Million
RM18.41 Million
≈ $4.62 Million
0.103x +305.99%
2023-12-31 RM160.98 Million
≈ $40.42 Million
RM-8.03 Million
≈ $-2.02 Million
-0.050x -113.38%
2022-12-31 RM153.34 Million
≈ $38.50 Million
RM-3.58 Million
≈ $-899.82K
-0.023x -127.45%
2021-12-31 RM131.36 Million
≈ $32.98 Million
RM11.19 Million
≈ $2.81 Million
0.085x -37.62%
2020-12-31 RM124.11 Million
≈ $31.16 Million
RM16.94 Million
≈ $4.25 Million
0.137x +97.44%
2019-12-31 RM107.33 Million
≈ $26.95 Million
RM7.42 Million
≈ $1.86 Million
0.069x +3.98%
2018-12-31 RM104.19 Million
≈ $26.16 Million
RM6.93 Million
≈ $1.74 Million
0.066x +50.29%
2017-12-31 RM102.43 Million
≈ $25.72 Million
RM4.53 Million
≈ $1.14 Million
0.044x -39.36%
2016-12-31 RM95.16 Million
≈ $23.89 Million
RM6.94 Million
≈ $1.74 Million
0.073x -51.50%
2015-12-31 RM55.60 Million
≈ $13.96 Million
RM8.36 Million
≈ $2.10 Million
0.150x --

About Rhone Ma Holdings Bhd

KLSE:5278 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$38.74 Million
RM154.30 Million MYR
Market Cap Rank
#22911 Global
#540 in Malaysia
Share Price
RM0.70
Change (1 day)
+0.72%
52-Week Range
RM0.61 - RM0.72
All Time High
RM1.04
About

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory servic… Read more